• Keytruda Conditionally Approved in US for Primary Mediastinal B-cell Lymphoma
  • Trial of Betalutin-Rituxan Combo as Second-line Follicular Lymphoma Therapy Poised to Launch in Norway
  • FDA Approves Venclexta-Rituxan Combo Therapy for CLL/SLL Patients
  • How Speaking Our Truth Can Help Us Heal
  • First Patient Dosed in Phase 2 Trial of eFT508 for Aggressive Non-Hodgkin’s Lymphoma
  • Xynomic Pharma Plans 4 Clinical Trials of Abexinostat for Lymphoma
  • First-line GEM-P Chemo Fails to Improve Response Rates in Peripheral T-cell Lymphomas, Results Show
  • This Is Why I’m Grateful for Cancer
  • Imbruvica-Rituxan Combo Significantly Delays Progression of Rare Type of Lymphoma in Phase 3 Trial
  • Cerdulatinib Shows Promising Phase 2a Trial Results in Blood Cancer Patients, Including NHL
  • Phase 3 Trial to Test Yescarta as Second-line Therapy for DLBCL Patients
  • Phase 2 Data Continues to Support Remetinostat in Easing Itching in Early Stage Mycosis Fungoides